Postmarketing safety and effectiveness of recombinant factor IX (nonacog alfa) in Japanese patients with haemophilia B.
Haemophilia
; 25(4): e247-e256, 2019 Jul.
Article
in En
| MEDLINE
| ID: mdl-31168882
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Product Surveillance, Postmarketing
/
Safety
/
Recombinant Proteins
/
Factor IX
/
Hemophilia B
Type of study:
Observational_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Haemophilia
Journal subject:
HEMATOLOGIA
Year:
2019
Document type:
Article
Affiliation country:
Japón